7.65
ABVC Biopharma Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
2.99
FY23:
1.66
FY24:
2.18
FY25:
2.50
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.04
FY22:
6.59
FY23:
6.13
FY24:
5.36
FY25:
18.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
13.7
FY22:
9.58
FY23:
7.78
FY24:
7.54
FY25:
21.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.69
FY22:
5.54
FY23:
6.10
FY24:
6.56
FY25:
6.16
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.14
FY22:
0.80
FY23:
0.43
FY24:
0.26
FY25:
1.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.84
FY22:
3.10
FY23:
1.55
FY24:
1.23
FY25:
11.1
Total liabilities & equity
Change from FY21 to FY24
millions USD
FY21:
13.7
FY22:
9.44
FY23:
8.09
FY24:
8.04
FY25:
–
All amounts in millions USD